|

Onfekafusp alfa Clinical Trials

2 actively recruiting trials

Also known as: L19TNF

Pipeline

Phase 3: 1Phase 1/2: 1

Top Sponsors

  • Philogen S.p.A.2

Indications

  • Cancer2
  • Soft Tissue Sarcoma1
  • Glioblastoma1

Other2 trials

A Study Comparing the Efficacy of L19TNF+Doxorubicin vs Doxorubicin Alone as First-line Therapy in Patients With Advanced or Metastatic Soft Tissue Sarcoma
Phase 3
Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.